Globus Medical Company Profile (NYSE:GMED)

About Globus Medical (NYSE:GMED)

Globus Medical logoGlobus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company's products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:GMED
  • CUSIP: 37957720
  • Web: www.globusmedical.com
Capitalization:
  • Market Cap: $3.1 billion
  • Outstanding Shares: 96,085,000
Average Prices:
  • 50 Day Moving Avg: $32.64
  • 200 Day Moving Avg: $29.64
  • 52 Week Range: $19.25 - $34.03
P/E:
  • Trailing P/E Ratio: 29.93
  • Foreward P/E Ratio: 22.74
  • P/E Growth: 2.33
Sales & Book Value:
  • Annual Revenue: $580.54 million
  • Price / Sales: 5.34
  • Book Value: $9.04 per share
  • Price / Book: 3.57
Profitability:
  • EBIDTA: $205.33 million
  • Net Margins: 18.09%
  • Return on Equity: 14.15%
  • Return on Assets: 12.73%
Debt:
  • Current Ratio: 7.18%
  • Quick Ratio: 5.68%
Misc:
  • Average Volume: 503,197 shs.
  • Beta: 0.62
  • Short Ratio: 17.69
 

Frequently Asked Questions for Globus Medical (NYSE:GMED)

What is Globus Medical's stock symbol?

Globus Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMED."

How were Globus Medical's earnings last quarter?

Globus Medical, Inc. (NYSE:GMED) issued its quarterly earnings results on Wednesday, May, 3rd. The company reported $0.32 EPS for the quarter, topping the Zacks' consensus estimate of $0.31 by $0.02. The business had revenue of $155.81 million for the quarter. Globus Medical had a return on equity of 14.15% and a net margin of 18.09%. View Globus Medical's Earnings History.

What guidance has Globus Medical issued on next quarter's earnings?

Globus Medical issued an update on its FY17 earnings guidance on Wednesday, May, 3rd. The company provided EPS guidance of $1.27 for the period, compared to the Thomson Reuters consensus estimate of $1.27. The company issued revenue guidance of $625 million, compared to the consensus revenue estimate of $625.03 million.

Where is Globus Medical's stock going? Where will Globus Medical's stock price be in 2017?

10 brokerages have issued twelve-month price objectives for Globus Medical's shares. Their predictions range from $23.00 to $37.00. On average, they expect Globus Medical's share price to reach $28.00 in the next year. View Analyst Ratings for Globus Medical.

What are analysts saying about Globus Medical stock?

Here are some recent quotes from research analysts about Globus Medical stock:

  • 1. According to Zacks Investment Research, "Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania. " (7/12/2017)
  • 2. Aegis analysts commented, "GMED reported 4Q16 non-GAAP EPS and revenues of $0.31 and $151.6 million (6.3%/6.5% cc), respectively, with EPS 2 cents short of our and consensus estimates and revenues in line with preliminary reported revenues. Gross margins for the quarter were 74.3%, down from 75.4% in 4Q15 due to one-time accounting adjustments and acquisition-related costs. Despite increasing investments, management maintained strong non-GAAP adjusted EBITDA margins of 37.7% though non-GAAP EPS fell short by 2 cents. During the call management emphasized that sales force issues are now behind them and, most importantly, that they expect to see a return to positive organic US growth in 1Q17. Management believes that this is the inflection point and is re-affirming FY2017 guidance of $625 million in revenues and $1.27 in EPS ' roughly 6.4% organic top-line growth. We believe US approval of its Excelsius GPS robot (expected by mid-year) and build out of its trauma business will provide upside to the business, where management is assuming a modest $10 million in emerging technologies contribution in 2017. We re-iterate our Buy rating and $31 TP." (2/28/2017)

Who are some of Globus Medical's key competitors?

Who owns Globus Medical stock?

Globus Medical's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Van Berkom & Associates Inc. (2.06%), GW&K Investment Management LLC (1.50%), Marathon Asset Management LLP (0.81%), BTIM Corp. (0.39%), RK Asset Management LLC (0.12%) and US Bancorp DE (0.04%). Company insiders that own Globus Medical stock include A Brett Murphy, Anthony L Williams, Kurt Wheeler and Robert Liptak. View Institutional Ownership Trends for Globus Medical.

Who sold Globus Medical stock? Who is selling Globus Medical stock?

Globus Medical's stock was sold by a variety of institutional investors in the last quarter, including BTIM Corp., GW&K Investment Management LLC, Capital Impact Advisors LLC, US Bancorp DE, OLD National Bancorp IN, Conservest Capital Advisors Inc. and Bank of Montreal Can. Company insiders that have sold Globus Medical stock in the last year include A Brett Murphy and Anthony L Williams. View Insider Buying and Selling for Globus Medical.

Who bought Globus Medical stock? Who is buying Globus Medical stock?

Globus Medical's stock was acquired by a variety of institutional investors in the last quarter, including Marathon Asset Management LLP, RK Asset Management LLC, Aperio Group LLC, Legato Capital Management LLC, Van Berkom & Associates Inc., Oregon Public Employees Retirement Fund, LS Investment Advisors LLC and State Treasurer State of Michigan. View Insider Buying and Selling for Globus Medical.

How do I buy Globus Medical stock?

Shares of Globus Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Globus Medical's stock price today?

One share of Globus Medical stock can currently be purchased for approximately $32.29.


MarketBeat Community Rating for Globus Medical (NYSE GMED)
Community Ranking:  3.1 out of 5 (  )
Outperform Votes:  256 (Vote Outperform)
Underperform Votes:  158 (Vote Underperform)
Total Votes:  414
MarketBeat's community ratings are surveys of what our community members think about Globus Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Globus Medical (NYSE:GMED) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $28.00 (13.29% downside)

Analysts' Ratings History for Globus Medical (NYSE:GMED)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/11/2017Morgan StanleyReiterated RatingEqual WeightLowView Rating Details
5/18/2017Oppenheimer Holdings, Inc.Reiterated RatingHoldLowView Rating Details
5/18/2017Canaccord GenuitySet Price TargetBuy$37.00LowView Rating Details
5/15/2017Barclays PLCReiterated RatingSell$30.00N/AView Rating Details
4/12/2017Leerink SwannUpgradeMarket Perform -> OutperformHighView Rating Details
2/28/2017AegisReiterated RatingBuy$31.00N/AView Rating Details
11/9/2016William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
11/9/2016Citigroup Inc.DowngradeMarket Perform$29.00 -> $23.00N/AView Rating Details
11/9/2016JMP SecuritiesDowngradeOutperform -> Market PerformN/AView Rating Details
7/27/2016Wells Fargo & CompanyDowngradeOutperform -> Market Perform$23.00N/AView Rating Details
6/25/2016Piper Jaffray CompaniesReiterated RatingOverweight$29.00N/AView Rating Details
5/26/2016Goldman Sachs Group, Inc. (The)DowngradeNeutral -> Sell$21.00N/AView Rating Details
5/4/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
1/8/2016Bank of America CorporationDowngradeBuy -> Underperform$28.00N/AView Rating Details
(Data available from 7/21/2015 forward)

Earnings

Earnings History for Globus Medical (NYSE:GMED)
Earnings by Quarter for Globus Medical (NYSE:GMED)
Earnings History by Quarter for Globus Medical (NYSE GMED)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017Q1 2017$0.31$0.32$155.81 millionViewListenView Earnings Details
2/27/2017Q416$0.33$0.31$149.30 million$151.59 millionViewListenView Earnings Details
11/8/2016Q3$0.28$0.29$139.25 million$135.70 millionViewListenView Earnings Details
7/26/2016Q2$0.29$0.29$141.78 million$137.49 millionViewListenView Earnings Details
5/3/2016Q1$0.28$0.29$140.30 million$139.30 millionViewListenView Earnings Details
2/24/2016Q4$0.30$0.32$141.20 million$142.60 millionViewListenView Earnings Details
11/3/2015Q3$0.25$0.28$127.46 million$137.00 millionViewListenView Earnings Details
7/30/2015Q215$0.25$0.25$126.89 million$133.60 millionViewListenView Earnings Details
5/5/2015Q115$0.24$0.26$122.30 million$131.60 millionViewListenView Earnings Details
2/25/2015Q414$0.25$0.30$127.77 million$128.80 millionViewListenView Earnings Details
10/30/2014Q314$0.21$0.24$113.10 million$117.80 millionViewListenView Earnings Details
8/5/2014Q214$0.23$0.23$119.83 million$113.60 millionViewListenView Earnings Details
4/29/2014Q114$0.22$0.24$113.59 million$114.20 millionViewListenView Earnings Details
2/26/2014Q413$0.22$0.25$114.96 million$115.20 millionViewListenView Earnings Details
10/30/2013Q313$0.19$0.22$106.00 million$107.19 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.20$0.21$107.46 million$107.00 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.20$0.21$103.14 million$105.00 millionViewListenView Earnings Details
2/27/2013Q4 2012$0.19$0.22$99.13 million$100.50 millionViewListenView Earnings Details
11/1/2012Q312$0.19$0.18$95.32 million$94.76 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Globus Medical (NYSE:GMED)
Current Year EPS Consensus Estimate: $1.27 EPS
Next Year EPS Consensus Estimate: $1.42 EPS

Dividends

Dividend History for Globus Medical (NYSE:GMED)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Globus Medical (NYSE:GMED)
Insider Ownership Percentage: 28.21%
Institutional Ownership Percentage: 68.91%
Insider Trades by Quarter for Globus Medical (NYSE:GMED)
Institutional Ownership by Quarter for Globus Medical (NYSE:GMED)
Insider Trades by Quarter for Globus Medical (NYSE:GMED)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/5/2017Anthony L WilliamsPresidentSell16,153$31.94$515,926.82View SEC Filing  
8/5/2016A Brett MurphyInsiderSell107,692$23.37$2,516,762.04View SEC Filing  
1/6/2016Robert LiptakDirectorSell15,300$27.50$420,750.00View SEC Filing  
1/4/2016Kurt WheelerDirectorSell255$27.50$7,012.50View SEC Filing  
5/28/2015Steven PayneCAOSell3,076$25.92$79,729.92View SEC Filing  
3/19/2015David C PaulCEOSell1,922,000$25.00$48,050,000.00View SEC Filing  
1/15/2014David DemskiCOOSell96,813$20.51$1,985,634.63View SEC Filing  
12/31/2013David DemskiCOOSell3,187$20.25$64,536.75View SEC Filing  
12/20/2013David DemskiCOOSell50,000$19.75$987,500.00View SEC Filing  
12/6/2013Robert LiptakDirectorSell25,000$19.36$484,000.00View SEC Filing  
12/3/2013David DavidarVPSell75,000$19.25$1,443,750.00View SEC Filing  
11/27/2013David DemskiCOOSell37,323$19.25$718,467.75View SEC Filing  
11/1/2013David M DemskiCOOSell112,677$18.59$2,094,665.43View SEC Filing  
8/23/2013David DavidarVPSell7,278$18.20$132,459.60View SEC Filing  
8/22/2013David DemskiCOOSell44,154$17.95$792,564.30View SEC Filing  
7/5/2013David D DavidarVPSell10,000$17.15$171,500.00View SEC Filing  
7/1/2013David D DavidarVPSell20,000$16.56$331,200.00View SEC Filing  
6/26/2013David D DavidarVPSell150,000$16.71$2,506,500.00View SEC Filing  
8/8/2012David C PaulCEOSell3,039,385$11.16$33,919,536.60View SEC Filing  
8/8/2012David D DavidarVPSell166,885$11.16$1,862,436.60View SEC Filing  
8/8/2012David M DemskiCOOSell98,957$11.16$1,104,360.12View SEC Filing  
8/8/2012Kurt WheelerDirectorSell804,232$11.16$8,975,229.12View SEC Filing  
8/8/2012Steven PayneCAOSell2,305$11.16$25,723.80View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Globus Medical (NYSE:GMED)
Latest Headlines for Globus Medical (NYSE:GMED)
Source:
DateHeadline
finance.yahoo.com logoGlobus Medical, Inc. breached its 50 day moving average in a Bearish Manner : GMED-US : July 19, 2017
finance.yahoo.com - July 19 at 7:48 PM
americanbankingnews.com logo$151.50 Million in Sales Expected for Globus Medical, Inc. (GMED) This Quarter
www.americanbankingnews.com - July 16 at 9:00 AM
americanbankingnews.com logoGlobus Medical (GMED) vs. Sunshine Heart (SSH) Financial Review
www.americanbankingnews.com - July 15 at 7:48 AM
americanbankingnews.com logoZacks: Brokerages Expect Globus Medical, Inc. (GMED) Will Post Earnings of $0.30 Per Share
www.americanbankingnews.com - July 14 at 11:15 AM
americanbankingnews.com logoFinancial Comparison: Globus Medical (GMED) and Integer Holdings (ITGR)
www.americanbankingnews.com - July 11 at 8:14 AM
americanbankingnews.com logoMorgan Stanley Reiterates Equal Weight Rating for Globus Medical, Inc. (NYSE:GMED)
www.americanbankingnews.com - July 11 at 7:06 AM
finance.yahoo.com logoETFs with exposure to Globus Medical, Inc. : July 10, 2017
finance.yahoo.com - July 10 at 7:05 PM
finance.yahoo.com logoGlobus Medical, Inc. – Value Analysis (NYSE:GMED) : July 10, 2017
finance.yahoo.com - July 10 at 7:05 PM
finance.yahoo.com logoGlobus Medical Schedules Second Quarter 2017 Earnings Release and Conference Call
finance.yahoo.com - July 10 at 7:05 PM
finance.yahoo.com logoGlobus Medical, Inc. breached its 50 day moving average in a Bearish Manner : GMED-US : July 7, 2017
finance.yahoo.com - July 8 at 11:06 AM
americanbankingnews.com logoGlobus Medical, Inc. (NYSE:GMED) Rating Lowered to Buy at BidaskClub
www.americanbankingnews.com - July 5 at 10:28 PM
americanbankingnews.com logoGlobus Medical, Inc. (NYSE:GMED) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 3 at 11:20 AM
finance.yahoo.com logoETFs with exposure to Globus Medical, Inc. : June 26, 2017
finance.yahoo.com - June 26 at 7:09 PM
americanbankingnews.com logoGlobus Medical, Inc. (GMED) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - June 23 at 12:58 AM
americanbankingnews.com logoZacks: Brokerages Anticipate Globus Medical, Inc. (GMED) Will Announce Quarterly Sales of $151.50 Million
www.americanbankingnews.com - June 22 at 12:00 PM
americanbankingnews.com logo Analysts Anticipate Globus Medical, Inc. (GMED) to Post $0.30 Earnings Per Share
www.americanbankingnews.com - June 20 at 8:18 AM
finance.yahoo.com logoETFs with exposure to Globus Medical, Inc. : June 13, 2017
finance.yahoo.com - June 13 at 5:15 PM
americanbankingnews.com logoGlobus Medical Inc (GMED) President Anthony L. Williams Sells 16,153 Shares
www.americanbankingnews.com - June 6 at 7:50 PM
americanbankingnews.com logoGlobus Medical Inc (GMED) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - June 6 at 9:02 AM
finance.yahoo.com logoETFs with exposure to Globus Medical, Inc. : June 2, 2017
finance.yahoo.com - June 2 at 6:49 PM
finance.yahoo.com logoGlobus Medical, Inc. :GMED-US: Earnings Analysis: Q1, 2017 By the Numbers : June 1, 2017
finance.yahoo.com - June 1 at 6:16 PM
americanbankingnews.com logo$151.5 Million in Sales Expected for Globus Medical Inc (GMED) This Quarter
www.americanbankingnews.com - May 27 at 10:04 AM
americanbankingnews.com logoGlobus Medical's (GMED) Hold Rating Reaffirmed at Oppenheimer Holdings Inc.
www.americanbankingnews.com - May 19 at 5:54 PM
americanbankingnews.com logoGlobus Medical Inc (GMED) Given a $37.00 Price Target at Canaccord Genuity
www.americanbankingnews.com - May 19 at 5:54 PM
americanbankingnews.com logoGlobus Medical Inc (GMED) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - May 12 at 11:20 PM
americanbankingnews.com logoGlobus Medical Inc (GMED) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - May 12 at 9:31 AM
americanbankingnews.com logoOppenheimer Holdings Inc. Reiterates "$32.00" Price Target for Globus Medical Inc (GMED)
www.americanbankingnews.com - May 7 at 7:34 AM
americanbankingnews.com logoBarclays PLC Reaffirms "Sell" Rating for Globus Medical Inc (GMED)
www.americanbankingnews.com - May 6 at 7:24 AM
americanbankingnews.com logoGlobus Medical Inc (GMED) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - May 5 at 11:26 PM
americanbankingnews.com logoGlobus Medical Inc (GMED) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - May 5 at 11:16 PM
americanbankingnews.com logoGlobus Medical Inc (GMED) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - May 5 at 5:00 PM
finance.yahoo.com logoEdited Transcript of GMED earnings conference call or presentation 3-May-17 9:30pm GMT
finance.yahoo.com - May 4 at 12:06 PM
americanbankingnews.com logoGlobus Medical Inc (GMED) Rating Increased to Buy at Canaccord Genuity
www.americanbankingnews.com - May 4 at 8:38 AM
americanbankingnews.com logoGlobus Medical Inc (GMED) Releases FY17 Earnings Guidance
www.americanbankingnews.com - May 4 at 1:02 AM
marketbeat.com logoGlobus Medical beats 1Q profit forecasts
marketbeat.com - May 3 at 7:59 PM
americanbankingnews.com logoSomewhat Positive Media Coverage Extremely Likely to Affect Globus Medical (GMED) Share Price
www.americanbankingnews.com - May 3 at 6:10 PM
finance.yahoo.com logoGlobus Medical Reports First Quarter 2017 Results
finance.yahoo.com - May 3 at 5:15 PM
seekingalpha.com logoGlobus Medical beats by $0.01, beats on revenue
seekingalpha.com - May 3 at 5:04 PM
americanbankingnews.com logoZacks: Analysts Expect Globus Medical Inc (GMED) Will Announce Quarterly Sales of $149.1 Million
www.americanbankingnews.com - May 3 at 12:25 PM
americanbankingnews.com logoZacks: Analysts Expect Globus Medical Inc (GMED) Will Announce Earnings of $0.31 Per Share
www.americanbankingnews.com - May 2 at 12:06 AM
finance.yahoo.com logoETFs with exposure to Globus Medical, Inc. : April 28, 2017
finance.yahoo.com - April 28 at 6:32 PM
americanbankingnews.com logoCritical Press Coverage Very Likely to Affect Globus Medical (GMED) Stock Price
www.americanbankingnews.com - April 27 at 3:00 PM
americanbankingnews.com logoGlobus Medical Inc (GMED) Downgraded by Barclays PLC
www.americanbankingnews.com - April 24 at 9:48 PM
americanbankingnews.com logoPositive News Coverage Very Likely to Affect Globus Medical (GMED) Share Price
www.americanbankingnews.com - April 24 at 4:52 PM
americanbankingnews.com logoGlobus Medical (GMED) Receiving Somewhat Favorable Media Coverage, Study Finds
www.americanbankingnews.com - April 21 at 8:46 PM
streetinsider.com logoGlobus Medical (GMED) Dismisses Grant Thornton as Independent Registered Public Accounting Firm
www.streetinsider.com - April 19 at 11:49 AM
americanbankingnews.com logoGlobus Medical (GMED) Earns Coverage Optimism Rating of 0.31
www.americanbankingnews.com - April 18 at 6:05 PM
finance.yahoo.com logoGlobus Medical Schedules First Quarter 2017 Earnings Release and Conference Call
finance.yahoo.com - April 17 at 4:57 PM
americanbankingnews.com logoGlobus Medical Inc (GMED) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - April 17 at 11:03 AM
americanbankingnews.com logoGlobus Medical Inc (GMED) Stock Rating Upgraded by Leerink Swann
www.americanbankingnews.com - April 13 at 12:05 AM

Social

Chart

Globus Medical (GMED) Chart for Friday, July, 21, 2017

This page was last updated on 7/21/2017 by MarketBeat.com Staff